
United States · Food & beverages startup
Nature's Fynd is a Chicago-based food-tech company that specializes in creating animal-free meat and dairy alternatives.
Funding reportedLast round: Series C
Nature's Fynd is a Chicago-based food-tech company that specializes in creating animal-free meat and dairy alternatives.
The company utilizes a unique nutritional fungi protein called FyTM, derived from a microbe discovered in Yellowstone National Park and optimized through NASA research. Nature's Fynd aims to nourish the growing global population while promoting environmental sustainability. The company produces a variety of products, including meatless breakfast patties and dairy-free cream cheese, all designed to be nutritious and delicious. FyTM is a complete protein source, containing all 20 amino acids, fiber, and low in fat, requiring significantly less water, land, and energy compared to traditional agriculture. Nature's Fynd's products are available in major grocery stores like Whole Foods and Sprouts, catering to consumers seeking vegan and sustainable food options. Founded by a team of explorers and scientists, Nature's Fynd has raised over $500 million in funding and continues to innovate in the food industry. The company operates a manufacturing facility in Chicago and conducts research and development in Bozeman, Montana.
Funding, as reported
What they build
Known for
low greenhouse gas emissionsalternative protein sourcesconsumershealthy breakfast choicesclimate-smart foodsdistributionmeatless pattiesmanufacturingcarbon footprint reductionfungi-powered nutritionbreakthrough fermentation technologyglobal food securitymicrobial fermentationinvestor-backed food innovationfood tech innovationnutrient dense
Built with from their website
Google Tag ManagerGoogle SheetsANSSpectroGoogle CloudGoogle AdsFlowIntel NiosGoogle WorkspacePinterest
CloudFlareViewport MetaFacebook SDKGoogle Cloud HostingGoogle MeetGoogle Font APISEOmaticMobile Friendly
Add your raise, your deck and your story, and put Nature's Fynd in front of investors. Or tell us what we have wrong.